30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Christine Poon

Performance

Overall performance
3.4

Performance over holding periods
3.4
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
27 4% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Prudential Financial Inc Sept. 1, 2006 -
Independent Director Regeneron Pharmaceuticals Inc Nov. 12, 2010 -
Independent Director Sherwin-Williams Co Jan. 1, 2014 -
Independent Vice Chairman of the Supervisory Board, Secretary Koninklijke Philips NV Jan. 1, 2014 -
Member of the Supervisory Board Koninklijke Philips NV March 27, 2009 - Jan. 1, 2014

Christine Poon's trades of Regeneron Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-10-31 2025-10-29 S Sale
36,609 -37.8%
384.09
US$3,513,462
36,609 -37.8% 384.09 US$3,513,462
2025-10-31 2025-10-29 S Sale
98,480 -47.6%
328.60
US$2,040,648
98,480 -47.6% 328.60 US$2,040,648
2025-10-31 2025-10-29 S Sale
86,167 +12.4%
369.39
US$3,660,934
86,167 +12.4% 369.39 US$3,660,934
2025-10-31 2025-10-29 S Sale
1,915 -35.0%
654.42
US$1,253,214
1,915 -35.0% 654.42 US$1,253,214
2025-10-31 2025-10-29 S Sale
2,735 -33.3%
653.50
US$1,787,322
2,735 -33.3% 653.50 US$1,787,322
2025-10-31 2025-10-29 S Sale
650 -7.3%
652.68
US$424,242
650 -7.3% 652.68 US$424,242
2025-10-29 2025-10-29 PrS Proposed sale
6,500
652.91
US$4,243,915
6,500 652.91 US$4,243,915
2024-08-19 2024-08-15 S Sale
100 -4.4%
1,161.32
US$116,132
100 -4.4% 1,161.32 US$116,132
2024-08-19 2024-08-15 S Sale
234 -9.3%
1,160.45
US$271,545
234 -9.3% 1,160.45 US$271,545
2024-08-19 2024-08-15 S Sale
5,352 -68.1%
1,159.56
US$6,205,965
5,352 -68.1% 1,159.56 US$6,205,965
2024-08-19 2024-08-15 S Sale
212 -2.6%
1,158.02
US$245,500
212 -2.6% 1,158.02 US$245,500
2024-08-19 2024-08-15 S Sale
1,560 -16.2%
1,157.33
US$1,805,435
1,560 -16.2% 1,157.33 US$1,805,435
2024-08-19 2024-08-15 S Sale
2,368 -19.7%
1,156.30
US$2,738,118
2,368 -19.7% 1,156.30 US$2,738,118
2024-08-19 2024-08-15 S Sale
1,012 -7.8%
1,155.72
US$1,169,589
1,012 -7.8% 1,155.72 US$1,169,589
2024-08-15 2024-08-15 PrS Proposed sale
10,838
1,156.86
US$12,538,049
10,838 1,156.86 US$12,538,049
2023-08-25 2023-08-23 S Sale
500 -19.7%
841.05
US$420,525
500 -19.7% 841.05 US$420,525
2023-08-25 2023-08-23 S Sale
6,450 -71.8%
840.65
US$5,422,192
6,450 -71.8% 840.65 US$5,422,192
2023-08-25 2023-08-23 S Sale
3,032 -25.2%
839.45
US$2,545,212
3,032 -25.2% 839.45 US$2,545,212
2023-08-25 2023-08-23 S Sale
1,998 -14.3%
838.60
US$1,675,523
1,998 -14.3% 838.60 US$1,675,523
2023-08-25 2023-08-23 S Sale
300 -2.1%
837.92
US$251,376
300 -2.1% 837.92 US$251,376
2023-08-23 2023-08-23 PrS Proposed sale
12,280
840.63
US$10,322,936
12,280 840.63 US$10,322,936
2022-08-11 2022-08-09 S Sale
8,186 -81.4%
621.27
US$5,085,716
8,186 -81.4% 621.27 US$5,085,716
2022-08-11 2022-08-09 S Sale
6,814 -40.4%
620.47
US$4,227,883
6,814 -40.4% 620.47 US$4,227,883
2020-08-31 2020-08-28 S Sale
693 -32.6%
603.20
US$418,018
693 -32.6% 603.20 US$418,018
2020-08-31 2020-08-28 S Sale
12,899 -85.9%
602.39
US$7,770,229
12,899 -85.9% 602.39 US$7,770,229
2020-08-31 2020-08-28 S Sale
8,011 -34.8%
601.53
US$4,818,857
8,011 -34.8% 601.53 US$4,818,857
2020-08-31 2020-08-28 S Sale
12,490 -35.2%
600.44
US$7,499,496
12,490 -35.2% 600.44 US$7,499,496
2020-08-31 2020-08-28 S Sale
5,730 -13.9%
599.67
US$3,436,109
5,730 -13.9% 599.67 US$3,436,109
2020-08-31 2020-08-28 S Sale
177 -0.4%
598.91
US$106,007
177 -0.4% 598.91 US$106,007
2008-05-15 2008-05-14 B Purchase
1,350 +inf%
74.35
US$100,372
1,350 +inf% 74.35 US$100,372